Recurrent focal segmental glomerulosclerosis: a discrete clinical entity.

Area of Science:

• Nephrology
• Genetics
• Pathology

Background:

• Focal segmental glomerulosclerosis (FSGS) is characterized by specific kidney lesions, often leading to steroid-resistant nephrotic syndrome and renal failure.
• Classifying primary nephrotic syndrome in children has been challenging due to the nonspecific nature of FSGS lesions.
• Hereditary FSGS, caused by mutations in podocyte slit diaphragm genes, highlights the distinct nature of certain FSGS forms.

Purpose of the Study:

• To review the natural history and pathogenesis of recurrent FSGS (R-FSGS) in renal allografts.
• To emphasize R-FSGS as a distinct clinical entity, particularly in light of genetic discoveries.
• To synthesize recent findings from genetic screening studies of slit diaphragm genes in FSGS patients.

Main Methods:

• Review of recent scientific literature focusing on FSGS.
• Analysis of studies involving genetic screening for slit diaphragm gene mutations.
• Examination of the clinical course and underlying mechanisms of R-FSGS.

Main Results:

• Recognition of hereditary FSGS provides a basis for understanding steroid-resistant forms.
• Recurrent FSGS (R-FSGS) in renal allografts is increasingly identified as a specific clinical entity.
• Genetic screening studies are crucial for differentiating FSGS subtypes and understanding pathogenesis.

Conclusions:

• Steroid-resistant FSGS recurring in renal allografts (R-FSGS) represents a distinct clinical entity.
• Understanding genetic mutations in podocyte slit diaphragm genes is key to elucidating R-FSGS pathogenesis.
• Further research into the natural history and genetics of R-FSGS is warranted.